SlideShare une entreprise Scribd logo
1  sur  13
STAFFORDSHIRE UNIVERSITY – SCIENCES(e-coversheet)
Please complete all shadedboxesand thencut-and-paste this e-coversheetintothe
front page of your assignment. Please ensure you record your registrationnumber
as failure to do so will resultin the lossof your anonymity.
By attaching this cover-sheetIdeclare that I have read the University’sAcademic
MisconductRegulations(includingplagiarism) and the work I am submittingdoes
NOT breach those regulations.
Award Title: BiologyBSc (Hons)
StudentRegistration Number: Date of Birth: 09/05/95
Module Code & Title:HUMAN BIOCHEMISTRY AND PHYSIOLOGY: BIOL50435
AssignmentDescription:Disease State Report
Module
Leader: Dr. David Skinglsey
SubmissionDeadline
Date: 23/01/2015
Word Limit:
3000
Word Count:
3033
DisabilityAllowance: Please tick as appropriate, if you have beenformally assessedas
having eitherdyslexiaor a hearing impairment. In such cases sympatheticallowance will
be made for spellingand writtenexpressionwhenmarking. For studentswho have a
support statementthat recommendsnegotiateddeadlinesyoushouldnegotiate with
these with your tutor in advance of the original submissiondate.
Dyslexia:
Hearing
Impairment:
Negotiated
Deadline:
To be completedby tutor
(N.B. The criteria below
may not all apply to this
assessmentand may not
be equallyweighted-
ticks are only indicative)
Excellent
Good
Satisfactory
Weak
Poor
Tutor Summary Comments:
(strengths/ weaknesses/actions to improve)
Relevance ofmaterial:
Evidence of
understanding:
Topic coveredin sufficient
depth:
Critical evaluationof
information:
Logical structure and
organisation:
Relevance & evidence of
background reading:
Effective referencing:
Clarity of writtenstyle
(includingEnglish):
Was a word-length
penaltyapplied?
Was the
assignmentlate?:
1st
marker’s
Initials:
2nd
marker’s
Initials:
Indicative
Grade-Point*:
* YOURGRADE IS SUBJECTTO FINALAPPROVAL BY THE AWARD BOARD
Viral Haemorrhagic Fever.
An insight into the biochemical and physiological
dysfunctions which are commonly associated.
Viral Haemorrhagicfever(VHFs) isaname givenreferringtoa groupof illnessesthatare causedby
several familiesof viruses,thistermisusedtodescribe asevere multisystemsyndromeinwhich
manyorgans withinthe bodyare effected.There are four maintaxonomicfamilies of viruseswhich
may cause a viral haemorrhagicfever,these are representedinfigure1.
As youcan see,dependingonthe responsibleVirusthe severity,withregardstofatalityrate,varies
fromup to 90% to lowerthan1%. The reasonfor thisrequiresanunderstandingof the different
challengesthateachvirusintroducestothe humanbodyonce an infectionhasoccurred.Depending
on the causative virus,the symptomsandclinical features thatoccurwithinthe bodyvary.The
severityof the altercationstothe body’snormal biochemistryandphysiology generally correlatesto
the virus’sfatalityrate.Due tothe highfatalityrate Iwill focusonthe Ebola virus;the causative virus
of EbolaHaemorrhagicFever(EHF),andthe challengesthe humanbodyispresentedwithupon and
duringan infection.
It isnecessarytonote that there are 5 speciesof Ebolavirus;Zaire,Bundibugyo,Sudan,Restonand
Taï Forest.Dependingonthe speciesthe symptomsmayvary,soto avoidconfusionthisreportwill
concernthe general biochemical andphysiological dysfunctionsthatmayoccur.EHF maylast forup
to 21 days,afterthe 4-10 dayincubationperiod,amultitude of biochemical andphysiological
altercationscanoccur duringthistime period(see figure2),howeverdetrimental effectspost-
infectionhave been reportedbyFormenty(1999) tolast up to 3 months.
Virus Family;(ViruseswithinFamily) Fatality rate
Filoviridae;(Ebolaand Marburg
viruses)
Ebola:50% to 90%,
Marburg: 23% to 70%
Arenaviridae;(NewWorld
haemorrhagic feverand Lassa fever)
New worldhaemorrhagicfever:15% to 30%,
Lassa fever:>1%
Bunyaviridae;(Rift Valleyfever,
Crimean-Congofever)
RiftValleyfever:14% to 17%
Crimean-Congofever:10% to 40%
Flaviviridae;(yellowfever,Omsk
haemorrhagic fever,Kyasanur Forest
disease)
Yellow fever:>50%
Omskhaemorrhagicfever:0.5% to 3%
KyasanurForestdisease:3% to10%
General Clinical features associated with (EHF).
Clinical Features Laboratory findingsdue toEHF
 vomiting,headache,prostration, fatigue
(< 1 week)
 Chestpain, Diarrhoea, Acute onsetof
fever,cough, pharyngitis
 Maculopapar rash
 Haemorrhagic manifestation
 Pancreatitis,hepatitis,conjunctival
inflammation
 CNS dysfunction
 Shock with DIC and organ failure ( < 7
days after symptoms begin)
 Sequelae:oculardisease,hearingloss,
pericarditis,arthralgia
 Leukopenia
 Leukocytosis
 Thrombocytopenia
 Elevatedliverenzymes
 Elevatedamylase
 Lab featuresof DIC
FIGURE 1. Represents virusesresponsible for causing viralhaemorrhagicfever with corresponding fatality rate. (S.F. Dept Public
health,2008).
FIGURE 2. Table displaying the general Clinical featuresand Laboratory findingsassociatedwith an EBOV infection (S.F. DeptPublic
health,2008)
Accordingto Lee & Sapphire (2009), Symptomsof EHF generally begintooccur withina4-10 day
incubationperiod,howeverinfatal cases,deathcanoccur as earlyas 6-9 daysafter onsetasa result
of uncontrolledviral replicationandmultiple organfailure.Tounderstandhow some of the
symptomswithintable 2become apparentwithinthe humanbody,itisnecessarytounderstandthe
initial stagesof EHF.Many studieshave beenconductedtodetermine the initialtargetcell of the
Ebolavirus (EBOV),andaccordingto Ströheret al (2001) morphological studiesonpost-mortem
material suggeststhatthe primarytargetfor viral replicationare;dendriticcellsandmacrophages
viaCD4 and CD8 receptors.These cellsare thenthoughttocirculate viathe lymphaticsystemto
regional lymphnodeswhere viral replicationcancontinue,andthe targetcell-associatedvirionsare
able to spread.HoweverEBOV isable toeffectothercellsindirectly,the virusdoesthisbyusing
infectedcellsalmostlikeabiochemical weapon,tocause dysfunctiontocellswhichdon’tappearto
be adequate hosts.
Lymphocytesare notdirectlyinfected byEBOV however,
studiesindicate thatlymphocyte apoptosisisaprominent
feature of infection(Bradfute etal,2010). It istherefore
hypothesisedthatfactorssecreted orexpressedbytarget
cellsare responsiblefortriggeringthe cell deathwithin
lymphocytes.Evidencesupportingthishypothesiscanbe
derivedfromastudyconductedbyGeisbertetal (2003),
data obtainedfromthisstudysuggestthatdendriticcells
and macrophagesincrease the expressionof tumour
necrosisfactor-α (TNFα) (see figure 3),aswell as
apoptosis-inducingligandandFastranscriptduringanEHF
infection.Thisdataissupportedbyseveral otherreports
statingsimilarresults (Formentyetal,1999), and mayhelp
to explainwhyLeukopeniatypicallyoccursduringthe
earlystagesof EHF. Asa resultof this the innate immune
response maybecome dysfunctional, leavingthe hostwith
little time toadaptivelyrespondtothe infection. Although
damage focuseswithin the lymphaticsysteminitially,itisalsostatedby Geisbertel al (2003a) that
whenEBOV entersthe blood system,the virus exhibitstissuetropismforthe;liver,adrenal gland
and spleen.
The Liverappearsto be an importanttargetof EBOV,data obtainedbyGeisbertetal (2003) suggests
that Kupffercellsare anadequate hostcell thus;viral replicationcontinueswithinthe Liver.Initial
infectionof the liveroccurswithinthe earlystagesof the infectioncausingdamage directlyto
hepatocytesandothercellsfoundwithinthe liver. Reportshave shownthatenzymes; Aspartate
aminotransferase,andAlanine aminotransferaseare bothelevated(see figure 4).Thissupports that
the viruscausesdamage to livertissue eitherdirectlyviareplicationorasa resultof a biochemical
imbalance due tofactorsreleaseduponcell lysis.
As a resultof the damage it maybe difficultforthe livertocontinue itsfunctionbothbiochemically
and physiologically,the liverplaysvitalroleswithinawide range of systemswithinthe body,
therefore progressiveliverdysfunctioncanbe catastrophictothe body’snormal homeostatic
procedures(see figure5).
FIGURE 3. Displaysthe increase ofTumour NecrosisFactor
during an EHF in Cynomolgusmacaques, data obtained by
Geisbert etal, (2003a).
POSSIBLE BIOCHEMICAL DYSFUNCTION
ASSOCIATED WITH LIVER DAMAGE; WITH
RELEVANCE TO EHF.
EFFECTS ON BODY DUE TO DYSFUNCTION.
- Inadequate secretionof precursor
molecule angiotensinogen.
- As the precursorto hormone
Angiotensin,inadequate amountsof
angiotensinogenmayinhibitthe
vasoconstrictionprocessthus
preventingvasoconstriction;aprocess
crucial for raisingbloodpressure and
slowingdown haemorrhage/acute
bloodloss.Thismayplaya role inthe
amplificationof the haemorrhagic
feature associatedwiththisinfection.
- Inadequate secretion,viathe liver,of
glycoproteinhormone;
thrombopoietin.
- Responsible forstimulating
Megakaryocytopoiesis,aninadequate
amountof thrombopoietinmayleadto
a reducedplateletproductionthus
directlyeffectingthrombusformation;
causingthrombocytopeniaandmassive
altercationstothe clottingcascade.
- Inabilitytosecrete/synthesizesufficient
quantitiesof glycogen
- Insufficientquantitiesof Glycogenmay
cause the bodyto entera
hypoglycaemicstate.Thisdysfunction
wouldrenderthe liveruselessan
unresponsive withinthe feedback
systemsimplementedforbloodglucose
homeostasis.
- Disruptiontothe livernormal
metabolicpathways
- Inabilityforthe livertocarry outits
normal metabolicfunctionsismassively
detrimental tothe body,asa resultof
such dysfunctionsmanysystemswithin
the bodywouldbe effected.In
particularthe Central NervousSystem
wouldnotreceive sufficient nutrients
to supportfunctionthuscausingCNS
dysfunction.
FIGURE 4. Biochemical valuesduring EHF; noteelevated ASTandALT. ALT-Alanine aminotransferase, AST-Aspartate
aminotransferase in comparisonto referencestandard. Data obtained by Formentyet al,(1999)
FIGURE 5. Showsexamplesof biochemical dysfunctionsthat may be causedby liver damage;an organ thatis largely damaged
during EHF.
In relationtothe liver,ithasbeenreportedthatnumerousorgansare manifestedwithEBOV during
EHF, for example Geisbertetal (2003) constructeda graph,showninfigure 6, whichrepresentssuch
activity.
In relationtothe liver,the adrenal glandappearstobe directlyaffectedbyEHF,data obtainedby
Geisbertetal,(2003a) indicatesthaton day 4 of an infectionEBOV wasdetectedinadrenal cortical
cellswithinthe zonafasciculate andzonareticularis. EBOV wasalsodetectedwithinstromacellsin
the adrenal cortex and withinfibrocytesinthe adrenal capsule,thisthenfurtherdevelopedinto
multifocal congestionof the adrenal cortex andmultifocal degradationof the adrenal cortical cells
(Geisbertetal,2003a). It isknowthat the adrenal cortex playsanimportantrole withinthe renin-
angiotensin-aldosterone systemwhichregulatesbloodpressure,figure7representsthisfeedback
system.
FIGURE 6. Showsmean infectivity of6 Cynomolgusmacaques; note themulti-organ involvement. LN-LymphNode. (Geisbertet al,
2003a)
FIGURE 7. A)Shows negativefeedback system involving kidneys and adrenalglands implementedfor controlofBlood pressure
homeostasis and thecontrol ofbloodelectrolytelevels. B)Adrenalcortex biochemicalinvolvement inthesynthesis ofhormones
Aldosteroneand Corticosterone. Image fromRossier (2010).
Adrenocortical necrosis,asaresultof EHF, has beenreportedinhumansbyFormentyetal, (1999),
and innon-humanprimatesby Geisbertetal, (2003a),thus renderingthe organunresponsive within
the negative feedbacksystemrepresentedinfigure 7a.Asa result of such dysfunctionthe adrenal
glandis be unable tosynthesizesufficientaldosterone,this preventsthe kidneyfromregulatingNa+
and K+
and, as a resultof this,ultimatelychronicbloodvolume;andthusbloodpressure (Boothetal,
2002). It is reportedbyFeldman(2011) that impairedsecretionof aldosterone leadstohypotension
and Na+
losswithhypovolaemia,therefore impairmentof adrenocortical functioncouldhave an
importantrole inthe shockthat typicallyoccursinlaterstagesof EHF. There are manyother
dysfunctionsthatoccurwithinthe body,the coagulationcascade alsoseemstobe largelyeffected
duringEHF.
A prominentmanifestationof EHFis disseminatedintravascularcoagulation(DIC),thisisthe
formationof microthrombi via activationof the clottingcascade.These microthrombi mayrestrict
bloodsupplytherefore maybe acontributingfactorto the multiple organdysfunctioncharacteristic
of EHF. Infact pathological dataobtainedbyGando(1999) suggeststhatfibrindepositionisafactor
that contributestomultipleorganfailure.Howeverbefore acute DICcanbecome apparentthere
mustbe sufficientstimulustooverwhelmthe natural anticoagulationprocesses (Feldmann&
Geisbert,2011). Anticoagulationfactors whichare mainlysynthesizedprimarilywithinthe liver
Parenchymal cells,whichhave mostlikelyalreadybeendamaged atthispointdue to viral assault,
act to inhibitthe formationof microthrombi,howeverif the rate at whichthese factorsare
consumedexceedsrate of synthesis;levelsof
inhibitorswithinplasmawill decline (Feldmann&
Geisbert,2011). For example Geisbertetal
(2003a) reportedthatactivatedProteinC,an
importantsubstance whichpreventsthrombus
formation,concentrationdropssignificantly
duringEHF (see figure 8);thisgoesto show that
the virusis able toovercome the body’snatural
anticoagulationsystems.
DuringDIC, the extrinsiccoagulationpathway,
whichisTissue Factor (TF) dependent,isthe
dominantroute forthrombinproductionand
thusfibrindeposition(Geisbertetal,2003b). The
factor that inducesDICwithinEHFismost likelyan
increase of TF,the majorinitiatorof the
coagulopathywitnessedwithinEHF,howeverin
orderto explainhowthisoccurswe
needtobeginwiththe initial targetof
EBOV;monocytes/macrophages.Data
obtainedby Geisbertetal,(2003b)
suggeststhatthe expressionof TFwas
onlyobserved in
monocytes/macrophagesthatshow
evidence of EBOV replication,thus
suggestingthatexpressionof TFmay
be directlyincreasedbyEBOV infection
(Geisbertetal,2003b).
FIGURE 8. ShowsconcentrationsofProtein C during EHF,
note the concentrationonly returns to 60% when
compared to pre-infectionconcentration.Data obtained
by Geisbert et al, (2003b).
FIGURE 9. Representsthe increase ofTF during EHF. Indirectfluorescent
antibodyanalysis was performedfor TF from peripheral blood mononuclear
cells ofanEBOV-infected rhesus macaqueat day 2 (B) andatday5 (C)
(Geisbertetal, 2003b).
As youcan see infigure 9, the concentrationof TF withinthe bloodincreasesduringthe progression
of an infection,thisishypothesizedby Geisbertetal (2003b) to be an importantfactorinthe
diagnosisof DICwithinEHF.DIC resultsinwidespreadactivationof the clottingcascade andthusthe
formationof multiplefibrinthrombi withinsmall vesselsthroughoutthe body.
As a resultof this,bloodflowisrestrictedthroughoutthe bodyandorgansreceive inadequate blood
supply,thisthenleadstoand/orhemorrhagicshock,whichappearstobe a lot like septicshock,
multiple organfailureandfinallydeathof the host(Geisbertetal,2003a); all featureswhichare
reportedby S.F.DeptPublichealth(2008) infigure 2.
Aroundday4-5, afterincubation,of EHF it may become clearwhetherthe hostismore likelyto
survive the infection, productionof antibodies,orwhetherthe infectionwillbe fatal, progressionto
hypercytokinemia,referredtoasthe “cytokine storm”;possiblythe final eventof EHF. It is
necessarytonote that thismay notoccur inall casesand dysfunctionswhichprecede thisstage may
be a significantfactorinthe deathof the host.Like manyof the symptomsassociatedwithEbola,
theymostlyall originate fromdysfunctionscausedtothe primarytargetcells. AccordingtoPérezet
al (2014), macrophage cellsare mainlyresponsibleforthe increasedsecretionof anti andpro-
inflammatorycytokinesduringEHF,thisreportalsoindicatesthatEBOV glycoprotein(GP) are the
likelyroute usedforactivationof the cytokinecascade viamacrophages,thisisshowninfigure 10.
As youcan see,endothelialcellsappeartobe affecteddue tothe release of cytokineswhichare
activatedandsecreteddue toEBOV GP. It has beenreportedbyWahl-Jensenetal (2005) that EBOV
causesa deregulatedinflammatorycytokine response,whichisresponsible inthe decreased
endothelial cellbarrierfunctionassociatedwiththisinfection.
FIGURE 10; Role ofshed GP during EHF. It is reported further by Pérez et al (2014) that EBOV GP aresecretedfrom infected cells, as
well as replicated virions, theseGP then bind tofurther cells using TLR-4,wherethey then activate thecells ability tosecrete various
cytokines. Image fromPérez et al(2014).
In fact studieshave shedfurtherlightonthisarea, Geisbertetal (2003c) emphasizedthe
involvementof TumorNecrosisFactor-α (TNFα) withinthe lossof vascularintegrity.TNFα isnow
consideredtobe the majorcytokine responsiblefor increasedpermeabilityof vasculartissue,and
data acquiredby Geisbertetal (2003c) supportsthis. InrelationtothisEBOV GP is able toinfect
endothelial cellsdirectly,thisproducescytopathiceffectsanddirectdamage tothe cellsbarrier,via
viral replication.Thisaccompaniedbythe cytokine effectsonendothelial cells leadstothe lossof
vascularintegrity,andasa resultlarge quantitiesof small breaksoccurthroughoutthe circulatory
systemamplifying;andfurtherreducing
bloodpressure.Incontrastto this
pressures,due tofluidleakage,within
organ cavitiesmayincrease,causing
excessivestresstoorganswhich,atthis
stage,may alreadybe dysfunctional,
causingfurtherdamage andamplifying
physiological damage. Inadditionto
thisit hasbeenreportedby Geisbertet
al (2003c) that withinendothelialcells,
small molecularweightproteinAlbumin
showsa significantdecreaseinvalue
whenthe cell become infected (see
figure 11),causinga vastnet decrease of
Albuminthroughoutthe body.Since itis
knowthat thisproteinhasa major function
inthe control of colloidosmoticpressure,anexcessive reducedamountwouldreduceplasma
osmoticpressure,thisdysfunctioncouldthenresultinedema. Furtherswellingtothe bodycould
induce furtherCNSdysfunctionandpossiblyleadtopermanentphysiological dysfunctionof organs
such as the brain(Geisbertetal,2003c).
It isalso thoughtthatduringthe late stagesof EHF, Nitricoxide (NO) levels begintoelevate(see
figure 12), possiblyasa response tothe heavyvirusloador may resultfromcytokine-induced
overexpressionof inducibleNOsynthase inphagocyticcellsthroughoutthe body(Sanchezetal.
(2004). Anincrease of NOwithinthe bloodcancause some seriousphysiological dysfunctions, for
example Sanchezetal (2004) reportedthatfatal
cases,whichexhibithighNOconcentrations,are
associatedwithcardiacstressandheart failure.It
alsosuggestedthatelevatedNOmaycontribute
to the hypotensioncharacteristicof EHF,as well
as the possibilityof thisfactorformingtoxic
molecule whichmayfurtherstressthe host.
To summarize EHFis capable of causing a wide
range of biochemical dysfunctions toahost, which
resultsina wide range of physiological
dysfunctionswithinthe humanbody;andnon-
humanprimates(Geisbertetal,2003a). Examples
withinthisreportare accompaniedwithmanyother
dysfunctionsthatoccurduringEHF.
Figure 12; Shows acomparisonoffatal and non-
fatal NOlevels in peripheral blood ofEbola-S
virus-infected
Patients. (Sanchezet al, 2004)
Figure 11; Showstotal serum protein and albumin valuespost-
infection in Cynomolgus monkeys. Note the decreaseofprotein
Albumin. Data obtainedfrom Geisbert etal, (2003c).
The initial attackappearsto be on monocyteswithinthe immune system, the virusisable to
transcribe andsynthesize variousfactorsandproteinswhichallow ittorecruitfurthercellsforviral
replication.Inthisprocessbiochemical imbalancesare created,causingothercells,suchas
lymphocytes, tobecome effected. Transportation,viathe lymphaticsystem,tothe spleenisthe
likelyroute usedtoenterthe vascularsystem, where the virus isthenable toaffectorganssuchas
the adrenal glandand the liverwhere necrosisoccurscausinglarge amountsof
physiological/biochemical dysfunction(Feldmanetal,2011). Asa resultof thisfurtherorganssuch
as the kidneysmaybecome effectedindirectlybyevenfurtherbiochemicalimbalancesdue to
necrosiswithinotherorgans.Forexamplethe kidneysinabilitytoregulate K+
andNa+
due
insufficientAldosterone synthesiswithinthe zonaglomerulosaof the adrenal gland,subsequently
causinghypotensionNa+
loss. InfactGeisbertetal,(2003a) foundthat almostall organsare effected
eitherdirectlyorin-directly,thishighlightsthe level of dysfunction,bothphysiological and
biochemical,whichoccursduringEHF.DIC alsooccurs whichresults ininadequate bloodsuppliesto
mostorgans throughoutthe body,resultinginmultiple organfailure andeventuallydeath.With
little treatmentavailable,therapiesonlyappearto rehydrate patientsinahope that theirimmune
systemwill produce antibodies.
If the hostsurvivesduring the multiple organfailureassociatedwithEHFthenthe infectionmay
progression intoitspreliminaryphase,which presentsamassive cytopathicattackon numerouscells
throughoutthe body.Thisiscombinedwithabodywide activationof masscytokine secretion,
causingconsiderate fluidlossanduncontrollablebleeding;deathmostlikelyfollowsthisphase.
Althoughactivationof the cytokine cascade isanimmune responsewhichusuallyoccursduring an
infectioncausedbyanewor particularlyharmful pathogen;italsoinflictsalarge amountof damage
to the host. In the unlikelysituationthatthe hostsurvivesthensubsequent conditionssuchas
deafnessandhairlosshave beenreportedbyFormenty etal,(1999).
So to trulyconclude;it’snotthe virusthat killsthe host,it’sthe hostsownbiochemical functionsand
immune responseswhichare hijackedduringEHFthat are the mostlikelycause of death.
References:
BOOTH, E, R. etal. (2002) Aldosterone. Advancesin Physiology Education. [Online] 26(8) p.2-20.
Available from:http://advan.physiology.org/content/ajpadvan/26/1/8.full.pdf [Accessed15/01/15]
BRADFUTE, B, S. etal. (2010) MechanismsandConsequencesof Ebolavirus-InducedLymphocyte
Apoptosis. TheJournalof Immunology. [Online] 184 (1).P.327-335. Availablefrom:
http://www.jimmunol.org/content/184/1/327.full.pdf+html [Accessed11/01/15]
FELDMANN,H. & GEISBERT, W, T. (2011) Ebolahaemorrhagicfever. NationalInstitution of Health.
[Online]377 (9768) p. 849-862. Available from:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406178/pdf/nihms390551.pdf [Accessed
10/01/15]
FORMENTY, P.et al.(1999) Human InfectionDue toEbolaVirus,Subtype Côte d’Ivoire:Clinical and
Biological Presentation. TheJournalof InfectiousDiseases [Online] 179(1) s.48-53. Availablefrom:
http://jid.oxfordjournals.org/content/179/Supplement_1/S48.full.pdf+html [Accessed8/01/15]
GANDO,S. NANZAKI,S&KEMMOTSU, O. (1999) Disseminatedintravascularcoagulationand
sustainedsystemicinflammatoryresponsesyndromepredictorgandysfunctions aftertrauma:
applicationof clinical decisionanalysis. Annalsof Surgery. [Online] 229(1) p. 121-127.Available from:
http://rh5pp9fz2b.scholar.serialssolutions.com/?sid=google&auinit=S&aulast=Gando&atitle=Dissem
inated+intravascular+coagulation+and+sustained+systemic+inflammatory+response+syndrome+pre
dict+organ+dysfunctions+after+trauma:+application+of+clinical+decision+analysis.&id=pmid:992380
9 [Accessed16/01/15]
GEISBERT, W, T. etal. (2003a) Pathogenesisof EbolaHemorrhagicFeverinCynomolgusMacaques.
American Journalof Pathology. 163 (6) p. 2347-2370. Available from:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892369/ [Accessed:11/01/15)
GEISBERT, W, T. et al.(2003b) MechanismsUnderlyingCoagulationAbnormalitiesinEbola
HemorrhagicFever:Overexpressionof Tissue FactorinPrimate Monocytes/MacrophagesIsaKey
Event. The Journalof InfectiousDisease. [Online] 188(11) p. 1618-1629. Available from:
http://jid.oxfordjournals.org/content/188/11/1618.full.pdf+html [Accessed16/01/15]
GEISBERT, W, T. et al.(2003c) Pathogenesisof EbolaHemorrhagicFeverin Primate ModelsEvidence
that Hemorrhage IsNota DirectEffectof Virus-InducedCytolysisof Endothelial Cells. American
Journalof Pathology. [Online] 163(6) p.2371-2382. Available from:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892396/pdf/3905.pdf [Accessed:21/01/15]
LEE, E, J.& SAPHIRE,O,E. (2009). Ebolavirusglycoproteinstructure andmechanismof entry.
NationalInstitution of Health. [Online] 4(6) p.621-635. Available from:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829775/pdf/nihms171807.pdf [Accessed
10/01/15]
PÉREZ, E, B. etal. (2014) ShedGP of Ebola VirusTriggersImmune ActivationandIncreasedVascular
Permeability. PLOSPathogens.[Online] 10(11) p.e1004509. Available from:
http://rh5pp9fz2b.search.serialssolutions.com/?ctx_ver=Z39.88-
2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-
8&rfr_id=info:sid/summon.serialssolutions.com&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre
=article&rft.atitle=Shed+GP+of+Ebola+Virus+Triggers+Immune+Activation+and+Increased+Vascular+
Permeability&rft.jtitle=PLOS+PATHOGENS&rft.au=Escudero-
Perez%2C+B&rft.au=Volchkova%2C+VA&rft.au=Dolnik%2C+O&rft.au=Lawrence%2C+P&rft.date=201
4-11-01&rft.pub=PUBLIC+LIBRARY+SCIENCE&rft.issn=1553-7366&rft.eissn=1553-
7374&rft.volume=10&rft.issue=11&rft_id=info:doi/10.1371%2Fjournal.ppat.1004509&rft.externalD
BID=n%2Fa&rft.externalDocID=000345515800032&paramdict=en-USv [Accessed20/01/15]
ROSSIER,C, B. (2010) Hypertensionfindsanew rhythm. NatureMedicine.[Online] 16(1) p-27-28.
Available from:http://www.nature.com/nm/journal/v16/n1/fig_tab/nm0110-27_ft.html [Accessed
17/01/15]
SANCHEZ,A.et al.(2004) Analysisof HumanPeripheral BloodSamplesfromFatal andNonfatal Cases
of Ebola(Sudan) HemorrhagicFever:CellularResponses,VirusLoad,andNitricOxide Levels. Journal
of Virology. [Online] 78(19). P. 10370-10377. Availablefrom:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC516433/pdf/2455-03.pdf [Accessed:21/01/15]
S.F.DEPT PUBLIC HEALTH, (July2008) Viral HemorrhagicFever. InfectiousDiseaseEmergencies.
[Online]p.1-18.Availablefrom:http://www.sfcdcp.org/document.html?id=316[Accessed8/01/15]
STRöHER, U. et al,(2001) InfectionandActivationof MonocytesbyMarburgand Ebolaviruses.
American Societyfor Microbiology:Journalof Virology [Online] 75(22/Nov) p.11025-11033.
Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC114683/pdf/jv2201011025.pdf
[Accessed10/01/15]
WAHL-JENSEN,M, V.etal, (2005) Effectsof EbolaVirusGlycoproteinsonEndothelialCell Activation
and BarrierFunction. Journalof Virology. [Online] 79(16) p.10442-10450. Available from:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1182673/pdf/2491-04.pdf [Accessed:21/01/15]

Contenu connexe

Tendances

Ebola in Sierra Leon: From the origin and transmission to clinical outcomes
Ebola in Sierra Leon: From the origin and transmission to clinical outcomes Ebola in Sierra Leon: From the origin and transmission to clinical outcomes
Ebola in Sierra Leon: From the origin and transmission to clinical outcomes GHMHI_MIT
 
Human Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent AbelHuman Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent AbelHuman Variome Project
 
Replication Competent IAV and IBV with Timer Article.PDF
Replication Competent IAV and IBV with Timer Article.PDFReplication Competent IAV and IBV with Timer Article.PDF
Replication Competent IAV and IBV with Timer Article.PDFMichael Breen
 
Investigating Foodborne Illness Outbreaks With Attorney William Marler
Investigating Foodborne Illness Outbreaks With Attorney William MarlerInvestigating Foodborne Illness Outbreaks With Attorney William Marler
Investigating Foodborne Illness Outbreaks With Attorney William MarlerBill Marler
 
Paul Ewald - Evolution as a Unifying Principle for Medical Sciences: The Case...
Paul Ewald - Evolution as a Unifying Principle for Medical Sciences: The Case...Paul Ewald - Evolution as a Unifying Principle for Medical Sciences: The Case...
Paul Ewald - Evolution as a Unifying Principle for Medical Sciences: The Case...Diego Alcaino
 
Pneumonia risk factors
Pneumonia risk factorsPneumonia risk factors
Pneumonia risk factorsJordi Roig
 
Corona virus latest research findings
Corona virus latest research findingsCorona virus latest research findings
Corona virus latest research findingsPRITAMBARDHAN2
 
Asif iqbal ppt Slides on cancer for defense
Asif iqbal ppt Slides on cancer for defenseAsif iqbal ppt Slides on cancer for defense
Asif iqbal ppt Slides on cancer for defenseASIF IQBAL KHAN
 
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...Asmallergie
 
Medcrave - MERS coronavirus - current status
Medcrave - MERS coronavirus - current statusMedcrave - MERS coronavirus - current status
Medcrave - MERS coronavirus - current statusMedCrave
 
Human Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and VaccinesHuman Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and VaccinesAbhijit Chaudhury
 
Genomic epidemiology of Campylobacter jejuni associated with asymptomatic pae...
Genomic epidemiology of Campylobacter jejuni associated with asymptomatic pae...Genomic epidemiology of Campylobacter jejuni associated with asymptomatic pae...
Genomic epidemiology of Campylobacter jejuni associated with asymptomatic pae...Ben Pascoe
 
Clinical Mycology U F Medical Students 12 05 07 Final2
Clinical Mycology  U F Medical Students 12 05 07 Final2Clinical Mycology  U F Medical Students 12 05 07 Final2
Clinical Mycology U F Medical Students 12 05 07 Final2raj kumar
 
Alan Moran_Thesis submission (1)
Alan Moran_Thesis submission (1)Alan Moran_Thesis submission (1)
Alan Moran_Thesis submission (1)Alan Moran
 
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...Rafael Monleon
 

Tendances (20)

Ebola in Sierra Leon: From the origin and transmission to clinical outcomes
Ebola in Sierra Leon: From the origin and transmission to clinical outcomes Ebola in Sierra Leon: From the origin and transmission to clinical outcomes
Ebola in Sierra Leon: From the origin and transmission to clinical outcomes
 
Human Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent AbelHuman Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent Abel
 
Replication Competent IAV and IBV with Timer Article.PDF
Replication Competent IAV and IBV with Timer Article.PDFReplication Competent IAV and IBV with Timer Article.PDF
Replication Competent IAV and IBV with Timer Article.PDF
 
Oncogenic virus
Oncogenic virusOncogenic virus
Oncogenic virus
 
Investigating Foodborne Illness Outbreaks With Attorney William Marler
Investigating Foodborne Illness Outbreaks With Attorney William MarlerInvestigating Foodborne Illness Outbreaks With Attorney William Marler
Investigating Foodborne Illness Outbreaks With Attorney William Marler
 
Paul Ewald - Evolution as a Unifying Principle for Medical Sciences: The Case...
Paul Ewald - Evolution as a Unifying Principle for Medical Sciences: The Case...Paul Ewald - Evolution as a Unifying Principle for Medical Sciences: The Case...
Paul Ewald - Evolution as a Unifying Principle for Medical Sciences: The Case...
 
Pneumonia risk factors
Pneumonia risk factorsPneumonia risk factors
Pneumonia risk factors
 
Corona virus latest research findings
Corona virus latest research findingsCorona virus latest research findings
Corona virus latest research findings
 
193768
193768193768
193768
 
Asif iqbal ppt Slides on cancer for defense
Asif iqbal ppt Slides on cancer for defenseAsif iqbal ppt Slides on cancer for defense
Asif iqbal ppt Slides on cancer for defense
 
Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in Hu...
Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in Hu...Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in Hu...
Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in Hu...
 
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
 
Medcrave - MERS coronavirus - current status
Medcrave - MERS coronavirus - current statusMedcrave - MERS coronavirus - current status
Medcrave - MERS coronavirus - current status
 
Human Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and VaccinesHuman Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and Vaccines
 
covid19 & ACE &TMPRSS2
covid19 & ACE &TMPRSS2covid19 & ACE &TMPRSS2
covid19 & ACE &TMPRSS2
 
Genomic epidemiology of Campylobacter jejuni associated with asymptomatic pae...
Genomic epidemiology of Campylobacter jejuni associated with asymptomatic pae...Genomic epidemiology of Campylobacter jejuni associated with asymptomatic pae...
Genomic epidemiology of Campylobacter jejuni associated with asymptomatic pae...
 
Duesberg Assignment
Duesberg AssignmentDuesberg Assignment
Duesberg Assignment
 
Clinical Mycology U F Medical Students 12 05 07 Final2
Clinical Mycology  U F Medical Students 12 05 07 Final2Clinical Mycology  U F Medical Students 12 05 07 Final2
Clinical Mycology U F Medical Students 12 05 07 Final2
 
Alan Moran_Thesis submission (1)
Alan Moran_Thesis submission (1)Alan Moran_Thesis submission (1)
Alan Moran_Thesis submission (1)
 
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
 

Similaire à Ebola Report, Human Biochemistry & Physiology.

Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...Alexander Decker
 
Mumps caused by a viral infection can cause sterility in males - Piril Erel
Mumps caused by a viral infection can cause sterility in males - Piril ErelMumps caused by a viral infection can cause sterility in males - Piril Erel
Mumps caused by a viral infection can cause sterility in males - Piril ErelPırıl Erel
 
Ebola research
Ebola research Ebola research
Ebola research Mavis Osei
 
An overview on ebola virus disease (evd) or ebola hemorrhagic fever (ehf)
An overview on ebola virus disease (evd) or ebola hemorrhagic fever (ehf)An overview on ebola virus disease (evd) or ebola hemorrhagic fever (ehf)
An overview on ebola virus disease (evd) or ebola hemorrhagic fever (ehf)pharmaindexing
 
estrategies infection, c. albicans and c. glabrata
estrategies infection, c. albicans and c. glabrataestrategies infection, c. albicans and c. glabrata
estrategies infection, c. albicans and c. glabrataIPN
 
EBOLA & OTHER VHF 2022.pptx
EBOLA & OTHER VHF 2022.pptxEBOLA & OTHER VHF 2022.pptx
EBOLA & OTHER VHF 2022.pptxMkindi Mkindi
 
Analysis in to the Epidemiology and Pathophysiology of Respiratory Syncytial ...
Analysis in to the Epidemiology and Pathophysiology of Respiratory Syncytial ...Analysis in to the Epidemiology and Pathophysiology of Respiratory Syncytial ...
Analysis in to the Epidemiology and Pathophysiology of Respiratory Syncytial ...Pırıl Erel
 
Cat Scratch Disease
Cat Scratch DiseaseCat Scratch Disease
Cat Scratch DiseaseMeiLing Lu
 
Sars cov 2 spike mutations paper los alamos
Sars cov 2 spike mutations paper los alamosSars cov 2 spike mutations paper los alamos
Sars cov 2 spike mutations paper los alamosJauru Freitas
 
Mono Research Paper
Mono Research PaperMono Research Paper
Mono Research PaperDiana Turner
 
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docx
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docxRunning Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docx
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docxglendar3
 
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docx
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docxRunning Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docx
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docxtodd581
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacyiosrphr_editor
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacyiosrphr_editor
 
Ebola virus disease - A comprehensive review
Ebola virus disease - A comprehensive reviewEbola virus disease - A comprehensive review
Ebola virus disease - A comprehensive reviewpharmaindexing
 
12Toxoplasmosis and Effects on Abortion, And Fetal A.docx
12Toxoplasmosis and Effects on Abortion, And Fetal A.docx12Toxoplasmosis and Effects on Abortion, And Fetal A.docx
12Toxoplasmosis and Effects on Abortion, And Fetal A.docxrobert345678
 

Similaire à Ebola Report, Human Biochemistry & Physiology. (20)

Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
 
Mumps caused by a viral infection can cause sterility in males - Piril Erel
Mumps caused by a viral infection can cause sterility in males - Piril ErelMumps caused by a viral infection can cause sterility in males - Piril Erel
Mumps caused by a viral infection can cause sterility in males - Piril Erel
 
Ebola research
Ebola research Ebola research
Ebola research
 
An overview on ebola virus disease (evd) or ebola hemorrhagic fever (ehf)
An overview on ebola virus disease (evd) or ebola hemorrhagic fever (ehf)An overview on ebola virus disease (evd) or ebola hemorrhagic fever (ehf)
An overview on ebola virus disease (evd) or ebola hemorrhagic fever (ehf)
 
estrategies infection, c. albicans and c. glabrata
estrategies infection, c. albicans and c. glabrataestrategies infection, c. albicans and c. glabrata
estrategies infection, c. albicans and c. glabrata
 
im
imim
im
 
Branche-Hors these
Branche-Hors theseBranche-Hors these
Branche-Hors these
 
EBOLA & OTHER VHF 2022.pptx
EBOLA & OTHER VHF 2022.pptxEBOLA & OTHER VHF 2022.pptx
EBOLA & OTHER VHF 2022.pptx
 
Analysis in to the Epidemiology and Pathophysiology of Respiratory Syncytial ...
Analysis in to the Epidemiology and Pathophysiology of Respiratory Syncytial ...Analysis in to the Epidemiology and Pathophysiology of Respiratory Syncytial ...
Analysis in to the Epidemiology and Pathophysiology of Respiratory Syncytial ...
 
McAlister_VME 158 Paper
McAlister_VME 158 Paper McAlister_VME 158 Paper
McAlister_VME 158 Paper
 
Cat Scratch Disease
Cat Scratch DiseaseCat Scratch Disease
Cat Scratch Disease
 
Sars cov 2 spike mutations paper los alamos
Sars cov 2 spike mutations paper los alamosSars cov 2 spike mutations paper los alamos
Sars cov 2 spike mutations paper los alamos
 
Mono Research Paper
Mono Research PaperMono Research Paper
Mono Research Paper
 
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docx
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docxRunning Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docx
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docx
 
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docx
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docxRunning Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docx
Running Head PATHOPHYSIOLOGY 1PATHOPHYSIOLOGY5.docx
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
 
Ebola virus disease - A comprehensive review
Ebola virus disease - A comprehensive reviewEbola virus disease - A comprehensive review
Ebola virus disease - A comprehensive review
 
12Toxoplasmosis and Effects on Abortion, And Fetal A.docx
12Toxoplasmosis and Effects on Abortion, And Fetal A.docx12Toxoplasmosis and Effects on Abortion, And Fetal A.docx
12Toxoplasmosis and Effects on Abortion, And Fetal A.docx
 
Salmonella enterica serotype choleraesuis
Salmonella enterica serotype choleraesuisSalmonella enterica serotype choleraesuis
Salmonella enterica serotype choleraesuis
 

Ebola Report, Human Biochemistry & Physiology.

  • 1. STAFFORDSHIRE UNIVERSITY – SCIENCES(e-coversheet) Please complete all shadedboxesand thencut-and-paste this e-coversheetintothe front page of your assignment. Please ensure you record your registrationnumber as failure to do so will resultin the lossof your anonymity. By attaching this cover-sheetIdeclare that I have read the University’sAcademic MisconductRegulations(includingplagiarism) and the work I am submittingdoes NOT breach those regulations. Award Title: BiologyBSc (Hons) StudentRegistration Number: Date of Birth: 09/05/95 Module Code & Title:HUMAN BIOCHEMISTRY AND PHYSIOLOGY: BIOL50435 AssignmentDescription:Disease State Report Module Leader: Dr. David Skinglsey SubmissionDeadline Date: 23/01/2015 Word Limit: 3000 Word Count: 3033 DisabilityAllowance: Please tick as appropriate, if you have beenformally assessedas having eitherdyslexiaor a hearing impairment. In such cases sympatheticallowance will be made for spellingand writtenexpressionwhenmarking. For studentswho have a support statementthat recommendsnegotiateddeadlinesyoushouldnegotiate with these with your tutor in advance of the original submissiondate. Dyslexia: Hearing Impairment: Negotiated Deadline: To be completedby tutor (N.B. The criteria below may not all apply to this assessmentand may not be equallyweighted- ticks are only indicative) Excellent Good Satisfactory Weak Poor Tutor Summary Comments: (strengths/ weaknesses/actions to improve) Relevance ofmaterial: Evidence of understanding: Topic coveredin sufficient depth: Critical evaluationof information: Logical structure and organisation: Relevance & evidence of background reading:
  • 2. Effective referencing: Clarity of writtenstyle (includingEnglish): Was a word-length penaltyapplied? Was the assignmentlate?: 1st marker’s Initials: 2nd marker’s Initials: Indicative Grade-Point*: * YOURGRADE IS SUBJECTTO FINALAPPROVAL BY THE AWARD BOARD
  • 3. Viral Haemorrhagic Fever. An insight into the biochemical and physiological dysfunctions which are commonly associated.
  • 4. Viral Haemorrhagicfever(VHFs) isaname givenreferringtoa groupof illnessesthatare causedby several familiesof viruses,thistermisusedtodescribe asevere multisystemsyndromeinwhich manyorgans withinthe bodyare effected.There are four maintaxonomicfamilies of viruseswhich may cause a viral haemorrhagicfever,these are representedinfigure1. As youcan see,dependingonthe responsibleVirusthe severity,withregardstofatalityrate,varies fromup to 90% to lowerthan1%. The reasonfor thisrequiresanunderstandingof the different challengesthateachvirusintroducestothe humanbodyonce an infectionhasoccurred.Depending on the causative virus,the symptomsandclinical features thatoccurwithinthe bodyvary.The severityof the altercationstothe body’snormal biochemistryandphysiology generally correlatesto the virus’sfatalityrate.Due tothe highfatalityrate Iwill focusonthe Ebola virus;the causative virus of EbolaHaemorrhagicFever(EHF),andthe challengesthe humanbodyispresentedwithupon and duringan infection. It isnecessarytonote that there are 5 speciesof Ebolavirus;Zaire,Bundibugyo,Sudan,Restonand Taï Forest.Dependingonthe speciesthe symptomsmayvary,soto avoidconfusionthisreportwill concernthe general biochemical andphysiological dysfunctionsthatmayoccur.EHF maylast forup to 21 days,afterthe 4-10 dayincubationperiod,amultitude of biochemical andphysiological altercationscanoccur duringthistime period(see figure2),howeverdetrimental effectspost- infectionhave been reportedbyFormenty(1999) tolast up to 3 months. Virus Family;(ViruseswithinFamily) Fatality rate Filoviridae;(Ebolaand Marburg viruses) Ebola:50% to 90%, Marburg: 23% to 70% Arenaviridae;(NewWorld haemorrhagic feverand Lassa fever) New worldhaemorrhagicfever:15% to 30%, Lassa fever:>1% Bunyaviridae;(Rift Valleyfever, Crimean-Congofever) RiftValleyfever:14% to 17% Crimean-Congofever:10% to 40% Flaviviridae;(yellowfever,Omsk haemorrhagic fever,Kyasanur Forest disease) Yellow fever:>50% Omskhaemorrhagicfever:0.5% to 3% KyasanurForestdisease:3% to10% General Clinical features associated with (EHF). Clinical Features Laboratory findingsdue toEHF  vomiting,headache,prostration, fatigue (< 1 week)  Chestpain, Diarrhoea, Acute onsetof fever,cough, pharyngitis  Maculopapar rash  Haemorrhagic manifestation  Pancreatitis,hepatitis,conjunctival inflammation  CNS dysfunction  Shock with DIC and organ failure ( < 7 days after symptoms begin)  Sequelae:oculardisease,hearingloss, pericarditis,arthralgia  Leukopenia  Leukocytosis  Thrombocytopenia  Elevatedliverenzymes  Elevatedamylase  Lab featuresof DIC FIGURE 1. Represents virusesresponsible for causing viralhaemorrhagicfever with corresponding fatality rate. (S.F. Dept Public health,2008). FIGURE 2. Table displaying the general Clinical featuresand Laboratory findingsassociatedwith an EBOV infection (S.F. DeptPublic health,2008)
  • 5. Accordingto Lee & Sapphire (2009), Symptomsof EHF generally begintooccur withina4-10 day incubationperiod,howeverinfatal cases,deathcanoccur as earlyas 6-9 daysafter onsetasa result of uncontrolledviral replicationandmultiple organfailure.Tounderstandhow some of the symptomswithintable 2become apparentwithinthe humanbody,itisnecessarytounderstandthe initial stagesof EHF.Many studieshave beenconductedtodetermine the initialtargetcell of the Ebolavirus (EBOV),andaccordingto Ströheret al (2001) morphological studiesonpost-mortem material suggeststhatthe primarytargetfor viral replicationare;dendriticcellsandmacrophages viaCD4 and CD8 receptors.These cellsare thenthoughttocirculate viathe lymphaticsystemto regional lymphnodeswhere viral replicationcancontinue,andthe targetcell-associatedvirionsare able to spread.HoweverEBOV isable toeffectothercellsindirectly,the virusdoesthisbyusing infectedcellsalmostlikeabiochemical weapon,tocause dysfunctiontocellswhichdon’tappearto be adequate hosts. Lymphocytesare notdirectlyinfected byEBOV however, studiesindicate thatlymphocyte apoptosisisaprominent feature of infection(Bradfute etal,2010). It istherefore hypothesisedthatfactorssecreted orexpressedbytarget cellsare responsiblefortriggeringthe cell deathwithin lymphocytes.Evidencesupportingthishypothesiscanbe derivedfromastudyconductedbyGeisbertetal (2003), data obtainedfromthisstudysuggestthatdendriticcells and macrophagesincrease the expressionof tumour necrosisfactor-α (TNFα) (see figure 3),aswell as apoptosis-inducingligandandFastranscriptduringanEHF infection.Thisdataissupportedbyseveral otherreports statingsimilarresults (Formentyetal,1999), and mayhelp to explainwhyLeukopeniatypicallyoccursduringthe earlystagesof EHF. Asa resultof this the innate immune response maybecome dysfunctional, leavingthe hostwith little time toadaptivelyrespondtothe infection. Although damage focuseswithin the lymphaticsysteminitially,itisalsostatedby Geisbertel al (2003a) that whenEBOV entersthe blood system,the virus exhibitstissuetropismforthe;liver,adrenal gland and spleen. The Liverappearsto be an importanttargetof EBOV,data obtainedbyGeisbertetal (2003) suggests that Kupffercellsare anadequate hostcell thus;viral replicationcontinueswithinthe Liver.Initial infectionof the liveroccurswithinthe earlystagesof the infectioncausingdamage directlyto hepatocytesandothercellsfoundwithinthe liver. Reportshave shownthatenzymes; Aspartate aminotransferase,andAlanine aminotransferaseare bothelevated(see figure 4).Thissupports that the viruscausesdamage to livertissue eitherdirectlyviareplicationorasa resultof a biochemical imbalance due tofactorsreleaseduponcell lysis. As a resultof the damage it maybe difficultforthe livertocontinue itsfunctionbothbiochemically and physiologically,the liverplaysvitalroleswithinawide range of systemswithinthe body, therefore progressiveliverdysfunctioncanbe catastrophictothe body’snormal homeostatic procedures(see figure5). FIGURE 3. Displaysthe increase ofTumour NecrosisFactor during an EHF in Cynomolgusmacaques, data obtained by Geisbert etal, (2003a).
  • 6. POSSIBLE BIOCHEMICAL DYSFUNCTION ASSOCIATED WITH LIVER DAMAGE; WITH RELEVANCE TO EHF. EFFECTS ON BODY DUE TO DYSFUNCTION. - Inadequate secretionof precursor molecule angiotensinogen. - As the precursorto hormone Angiotensin,inadequate amountsof angiotensinogenmayinhibitthe vasoconstrictionprocessthus preventingvasoconstriction;aprocess crucial for raisingbloodpressure and slowingdown haemorrhage/acute bloodloss.Thismayplaya role inthe amplificationof the haemorrhagic feature associatedwiththisinfection. - Inadequate secretion,viathe liver,of glycoproteinhormone; thrombopoietin. - Responsible forstimulating Megakaryocytopoiesis,aninadequate amountof thrombopoietinmayleadto a reducedplateletproductionthus directlyeffectingthrombusformation; causingthrombocytopeniaandmassive altercationstothe clottingcascade. - Inabilitytosecrete/synthesizesufficient quantitiesof glycogen - Insufficientquantitiesof Glycogenmay cause the bodyto entera hypoglycaemicstate.Thisdysfunction wouldrenderthe liveruselessan unresponsive withinthe feedback systemsimplementedforbloodglucose homeostasis. - Disruptiontothe livernormal metabolicpathways - Inabilityforthe livertocarry outits normal metabolicfunctionsismassively detrimental tothe body,asa resultof such dysfunctionsmanysystemswithin the bodywouldbe effected.In particularthe Central NervousSystem wouldnotreceive sufficient nutrients to supportfunctionthuscausingCNS dysfunction. FIGURE 4. Biochemical valuesduring EHF; noteelevated ASTandALT. ALT-Alanine aminotransferase, AST-Aspartate aminotransferase in comparisonto referencestandard. Data obtained by Formentyet al,(1999) FIGURE 5. Showsexamplesof biochemical dysfunctionsthat may be causedby liver damage;an organ thatis largely damaged during EHF.
  • 7. In relationtothe liver,ithasbeenreportedthatnumerousorgansare manifestedwithEBOV during EHF, for example Geisbertetal (2003) constructeda graph,showninfigure 6, whichrepresentssuch activity. In relationtothe liver,the adrenal glandappearstobe directlyaffectedbyEHF,data obtainedby Geisbertetal,(2003a) indicatesthaton day 4 of an infectionEBOV wasdetectedinadrenal cortical cellswithinthe zonafasciculate andzonareticularis. EBOV wasalsodetectedwithinstromacellsin the adrenal cortex and withinfibrocytesinthe adrenal capsule,thisthenfurtherdevelopedinto multifocal congestionof the adrenal cortex andmultifocal degradationof the adrenal cortical cells (Geisbertetal,2003a). It isknowthat the adrenal cortex playsanimportantrole withinthe renin- angiotensin-aldosterone systemwhichregulatesbloodpressure,figure7representsthisfeedback system. FIGURE 6. Showsmean infectivity of6 Cynomolgusmacaques; note themulti-organ involvement. LN-LymphNode. (Geisbertet al, 2003a) FIGURE 7. A)Shows negativefeedback system involving kidneys and adrenalglands implementedfor controlofBlood pressure homeostasis and thecontrol ofbloodelectrolytelevels. B)Adrenalcortex biochemicalinvolvement inthesynthesis ofhormones Aldosteroneand Corticosterone. Image fromRossier (2010).
  • 8. Adrenocortical necrosis,asaresultof EHF, has beenreportedinhumansbyFormentyetal, (1999), and innon-humanprimatesby Geisbertetal, (2003a),thus renderingthe organunresponsive within the negative feedbacksystemrepresentedinfigure 7a.Asa result of such dysfunctionthe adrenal glandis be unable tosynthesizesufficientaldosterone,this preventsthe kidneyfromregulatingNa+ and K+ and, as a resultof this,ultimatelychronicbloodvolume;andthusbloodpressure (Boothetal, 2002). It is reportedbyFeldman(2011) that impairedsecretionof aldosterone leadstohypotension and Na+ losswithhypovolaemia,therefore impairmentof adrenocortical functioncouldhave an importantrole inthe shockthat typicallyoccursinlaterstagesof EHF. There are manyother dysfunctionsthatoccurwithinthe body,the coagulationcascade alsoseemstobe largelyeffected duringEHF. A prominentmanifestationof EHFis disseminatedintravascularcoagulation(DIC),thisisthe formationof microthrombi via activationof the clottingcascade.These microthrombi mayrestrict bloodsupplytherefore maybe acontributingfactorto the multiple organdysfunctioncharacteristic of EHF. Infact pathological dataobtainedbyGando(1999) suggeststhatfibrindepositionisafactor that contributestomultipleorganfailure.Howeverbefore acute DICcanbecome apparentthere mustbe sufficientstimulustooverwhelmthe natural anticoagulationprocesses (Feldmann& Geisbert,2011). Anticoagulationfactors whichare mainlysynthesizedprimarilywithinthe liver Parenchymal cells,whichhave mostlikelyalreadybeendamaged atthispointdue to viral assault, act to inhibitthe formationof microthrombi,howeverif the rate at whichthese factorsare consumedexceedsrate of synthesis;levelsof inhibitorswithinplasmawill decline (Feldmann& Geisbert,2011). For example Geisbertetal (2003a) reportedthatactivatedProteinC,an importantsubstance whichpreventsthrombus formation,concentrationdropssignificantly duringEHF (see figure 8);thisgoesto show that the virusis able toovercome the body’snatural anticoagulationsystems. DuringDIC, the extrinsiccoagulationpathway, whichisTissue Factor (TF) dependent,isthe dominantroute forthrombinproductionand thusfibrindeposition(Geisbertetal,2003b). The factor that inducesDICwithinEHFismost likelyan increase of TF,the majorinitiatorof the coagulopathywitnessedwithinEHF,howeverin orderto explainhowthisoccurswe needtobeginwiththe initial targetof EBOV;monocytes/macrophages.Data obtainedby Geisbertetal,(2003b) suggeststhatthe expressionof TFwas onlyobserved in monocytes/macrophagesthatshow evidence of EBOV replication,thus suggestingthatexpressionof TFmay be directlyincreasedbyEBOV infection (Geisbertetal,2003b). FIGURE 8. ShowsconcentrationsofProtein C during EHF, note the concentrationonly returns to 60% when compared to pre-infectionconcentration.Data obtained by Geisbert et al, (2003b). FIGURE 9. Representsthe increase ofTF during EHF. Indirectfluorescent antibodyanalysis was performedfor TF from peripheral blood mononuclear cells ofanEBOV-infected rhesus macaqueat day 2 (B) andatday5 (C) (Geisbertetal, 2003b).
  • 9. As youcan see infigure 9, the concentrationof TF withinthe bloodincreasesduringthe progression of an infection,thisishypothesizedby Geisbertetal (2003b) to be an importantfactorinthe diagnosisof DICwithinEHF.DIC resultsinwidespreadactivationof the clottingcascade andthusthe formationof multiplefibrinthrombi withinsmall vesselsthroughoutthe body. As a resultof this,bloodflowisrestrictedthroughoutthe bodyandorgansreceive inadequate blood supply,thisthenleadstoand/orhemorrhagicshock,whichappearstobe a lot like septicshock, multiple organfailureandfinallydeathof the host(Geisbertetal,2003a); all featureswhichare reportedby S.F.DeptPublichealth(2008) infigure 2. Aroundday4-5, afterincubation,of EHF it may become clearwhetherthe hostismore likelyto survive the infection, productionof antibodies,orwhetherthe infectionwillbe fatal, progressionto hypercytokinemia,referredtoasthe “cytokine storm”;possiblythe final eventof EHF. It is necessarytonote that thismay notoccur inall casesand dysfunctionswhichprecede thisstage may be a significantfactorinthe deathof the host.Like manyof the symptomsassociatedwithEbola, theymostlyall originate fromdysfunctionscausedtothe primarytargetcells. AccordingtoPérezet al (2014), macrophage cellsare mainlyresponsibleforthe increasedsecretionof anti andpro- inflammatorycytokinesduringEHF,thisreportalsoindicatesthatEBOV glycoprotein(GP) are the likelyroute usedforactivationof the cytokinecascade viamacrophages,thisisshowninfigure 10. As youcan see,endothelialcellsappeartobe affecteddue tothe release of cytokineswhichare activatedandsecreteddue toEBOV GP. It has beenreportedbyWahl-Jensenetal (2005) that EBOV causesa deregulatedinflammatorycytokine response,whichisresponsible inthe decreased endothelial cellbarrierfunctionassociatedwiththisinfection. FIGURE 10; Role ofshed GP during EHF. It is reported further by Pérez et al (2014) that EBOV GP aresecretedfrom infected cells, as well as replicated virions, theseGP then bind tofurther cells using TLR-4,wherethey then activate thecells ability tosecrete various cytokines. Image fromPérez et al(2014).
  • 10. In fact studieshave shedfurtherlightonthisarea, Geisbertetal (2003c) emphasizedthe involvementof TumorNecrosisFactor-α (TNFα) withinthe lossof vascularintegrity.TNFα isnow consideredtobe the majorcytokine responsiblefor increasedpermeabilityof vasculartissue,and data acquiredby Geisbertetal (2003c) supportsthis. InrelationtothisEBOV GP is able toinfect endothelial cellsdirectly,thisproducescytopathiceffectsanddirectdamage tothe cellsbarrier,via viral replication.Thisaccompaniedbythe cytokine effectsonendothelial cells leadstothe lossof vascularintegrity,andasa resultlarge quantitiesof small breaksoccurthroughoutthe circulatory systemamplifying;andfurtherreducing bloodpressure.Incontrastto this pressures,due tofluidleakage,within organ cavitiesmayincrease,causing excessivestresstoorganswhich,atthis stage,may alreadybe dysfunctional, causingfurtherdamage andamplifying physiological damage. Inadditionto thisit hasbeenreportedby Geisbertet al (2003c) that withinendothelialcells, small molecularweightproteinAlbumin showsa significantdecreaseinvalue whenthe cell become infected (see figure 11),causinga vastnet decrease of Albuminthroughoutthe body.Since itis knowthat thisproteinhasa major function inthe control of colloidosmoticpressure,anexcessive reducedamountwouldreduceplasma osmoticpressure,thisdysfunctioncouldthenresultinedema. Furtherswellingtothe bodycould induce furtherCNSdysfunctionandpossiblyleadtopermanentphysiological dysfunctionof organs such as the brain(Geisbertetal,2003c). It isalso thoughtthatduringthe late stagesof EHF, Nitricoxide (NO) levels begintoelevate(see figure 12), possiblyasa response tothe heavyvirusloador may resultfromcytokine-induced overexpressionof inducibleNOsynthase inphagocyticcellsthroughoutthe body(Sanchezetal. (2004). Anincrease of NOwithinthe bloodcancause some seriousphysiological dysfunctions, for example Sanchezetal (2004) reportedthatfatal cases,whichexhibithighNOconcentrations,are associatedwithcardiacstressandheart failure.It alsosuggestedthatelevatedNOmaycontribute to the hypotensioncharacteristicof EHF,as well as the possibilityof thisfactorformingtoxic molecule whichmayfurtherstressthe host. To summarize EHFis capable of causing a wide range of biochemical dysfunctions toahost, which resultsina wide range of physiological dysfunctionswithinthe humanbody;andnon- humanprimates(Geisbertetal,2003a). Examples withinthisreportare accompaniedwithmanyother dysfunctionsthatoccurduringEHF. Figure 12; Shows acomparisonoffatal and non- fatal NOlevels in peripheral blood ofEbola-S virus-infected Patients. (Sanchezet al, 2004) Figure 11; Showstotal serum protein and albumin valuespost- infection in Cynomolgus monkeys. Note the decreaseofprotein Albumin. Data obtainedfrom Geisbert etal, (2003c).
  • 11. The initial attackappearsto be on monocyteswithinthe immune system, the virusisable to transcribe andsynthesize variousfactorsandproteinswhichallow ittorecruitfurthercellsforviral replication.Inthisprocessbiochemical imbalancesare created,causingothercells,suchas lymphocytes, tobecome effected. Transportation,viathe lymphaticsystem,tothe spleenisthe likelyroute usedtoenterthe vascularsystem, where the virus isthenable toaffectorganssuchas the adrenal glandand the liverwhere necrosisoccurscausinglarge amountsof physiological/biochemical dysfunction(Feldmanetal,2011). Asa resultof thisfurtherorganssuch as the kidneysmaybecome effectedindirectlybyevenfurtherbiochemicalimbalancesdue to necrosiswithinotherorgans.Forexamplethe kidneysinabilitytoregulate K+ andNa+ due insufficientAldosterone synthesiswithinthe zonaglomerulosaof the adrenal gland,subsequently causinghypotensionNa+ loss. InfactGeisbertetal,(2003a) foundthat almostall organsare effected eitherdirectlyorin-directly,thishighlightsthe level of dysfunction,bothphysiological and biochemical,whichoccursduringEHF.DIC alsooccurs whichresults ininadequate bloodsuppliesto mostorgans throughoutthe body,resultinginmultiple organfailure andeventuallydeath.With little treatmentavailable,therapiesonlyappearto rehydrate patientsinahope that theirimmune systemwill produce antibodies. If the hostsurvivesduring the multiple organfailureassociatedwithEHFthenthe infectionmay progression intoitspreliminaryphase,which presentsamassive cytopathicattackon numerouscells throughoutthe body.Thisiscombinedwithabodywide activationof masscytokine secretion, causingconsiderate fluidlossanduncontrollablebleeding;deathmostlikelyfollowsthisphase. Althoughactivationof the cytokine cascade isanimmune responsewhichusuallyoccursduring an infectioncausedbyanewor particularlyharmful pathogen;italsoinflictsalarge amountof damage to the host. In the unlikelysituationthatthe hostsurvivesthensubsequent conditionssuchas deafnessandhairlosshave beenreportedbyFormenty etal,(1999). So to trulyconclude;it’snotthe virusthat killsthe host,it’sthe hostsownbiochemical functionsand immune responseswhichare hijackedduringEHFthat are the mostlikelycause of death.
  • 12. References: BOOTH, E, R. etal. (2002) Aldosterone. Advancesin Physiology Education. [Online] 26(8) p.2-20. Available from:http://advan.physiology.org/content/ajpadvan/26/1/8.full.pdf [Accessed15/01/15] BRADFUTE, B, S. etal. (2010) MechanismsandConsequencesof Ebolavirus-InducedLymphocyte Apoptosis. TheJournalof Immunology. [Online] 184 (1).P.327-335. Availablefrom: http://www.jimmunol.org/content/184/1/327.full.pdf+html [Accessed11/01/15] FELDMANN,H. & GEISBERT, W, T. (2011) Ebolahaemorrhagicfever. NationalInstitution of Health. [Online]377 (9768) p. 849-862. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406178/pdf/nihms390551.pdf [Accessed 10/01/15] FORMENTY, P.et al.(1999) Human InfectionDue toEbolaVirus,Subtype Côte d’Ivoire:Clinical and Biological Presentation. TheJournalof InfectiousDiseases [Online] 179(1) s.48-53. Availablefrom: http://jid.oxfordjournals.org/content/179/Supplement_1/S48.full.pdf+html [Accessed8/01/15] GANDO,S. NANZAKI,S&KEMMOTSU, O. (1999) Disseminatedintravascularcoagulationand sustainedsystemicinflammatoryresponsesyndromepredictorgandysfunctions aftertrauma: applicationof clinical decisionanalysis. Annalsof Surgery. [Online] 229(1) p. 121-127.Available from: http://rh5pp9fz2b.scholar.serialssolutions.com/?sid=google&auinit=S&aulast=Gando&atitle=Dissem inated+intravascular+coagulation+and+sustained+systemic+inflammatory+response+syndrome+pre dict+organ+dysfunctions+after+trauma:+application+of+clinical+decision+analysis.&id=pmid:992380 9 [Accessed16/01/15] GEISBERT, W, T. etal. (2003a) Pathogenesisof EbolaHemorrhagicFeverinCynomolgusMacaques. American Journalof Pathology. 163 (6) p. 2347-2370. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892369/ [Accessed:11/01/15) GEISBERT, W, T. et al.(2003b) MechanismsUnderlyingCoagulationAbnormalitiesinEbola HemorrhagicFever:Overexpressionof Tissue FactorinPrimate Monocytes/MacrophagesIsaKey Event. The Journalof InfectiousDisease. [Online] 188(11) p. 1618-1629. Available from: http://jid.oxfordjournals.org/content/188/11/1618.full.pdf+html [Accessed16/01/15] GEISBERT, W, T. et al.(2003c) Pathogenesisof EbolaHemorrhagicFeverin Primate ModelsEvidence that Hemorrhage IsNota DirectEffectof Virus-InducedCytolysisof Endothelial Cells. American Journalof Pathology. [Online] 163(6) p.2371-2382. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892396/pdf/3905.pdf [Accessed:21/01/15] LEE, E, J.& SAPHIRE,O,E. (2009). Ebolavirusglycoproteinstructure andmechanismof entry. NationalInstitution of Health. [Online] 4(6) p.621-635. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829775/pdf/nihms171807.pdf [Accessed 10/01/15] PÉREZ, E, B. etal. (2014) ShedGP of Ebola VirusTriggersImmune ActivationandIncreasedVascular Permeability. PLOSPathogens.[Online] 10(11) p.e1004509. Available from: http://rh5pp9fz2b.search.serialssolutions.com/?ctx_ver=Z39.88- 2004&ctx_enc=info%3Aofi%2Fenc%3AUTF- 8&rfr_id=info:sid/summon.serialssolutions.com&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre =article&rft.atitle=Shed+GP+of+Ebola+Virus+Triggers+Immune+Activation+and+Increased+Vascular+ Permeability&rft.jtitle=PLOS+PATHOGENS&rft.au=Escudero-
  • 13. Perez%2C+B&rft.au=Volchkova%2C+VA&rft.au=Dolnik%2C+O&rft.au=Lawrence%2C+P&rft.date=201 4-11-01&rft.pub=PUBLIC+LIBRARY+SCIENCE&rft.issn=1553-7366&rft.eissn=1553- 7374&rft.volume=10&rft.issue=11&rft_id=info:doi/10.1371%2Fjournal.ppat.1004509&rft.externalD BID=n%2Fa&rft.externalDocID=000345515800032&paramdict=en-USv [Accessed20/01/15] ROSSIER,C, B. (2010) Hypertensionfindsanew rhythm. NatureMedicine.[Online] 16(1) p-27-28. Available from:http://www.nature.com/nm/journal/v16/n1/fig_tab/nm0110-27_ft.html [Accessed 17/01/15] SANCHEZ,A.et al.(2004) Analysisof HumanPeripheral BloodSamplesfromFatal andNonfatal Cases of Ebola(Sudan) HemorrhagicFever:CellularResponses,VirusLoad,andNitricOxide Levels. Journal of Virology. [Online] 78(19). P. 10370-10377. Availablefrom: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC516433/pdf/2455-03.pdf [Accessed:21/01/15] S.F.DEPT PUBLIC HEALTH, (July2008) Viral HemorrhagicFever. InfectiousDiseaseEmergencies. [Online]p.1-18.Availablefrom:http://www.sfcdcp.org/document.html?id=316[Accessed8/01/15] STRöHER, U. et al,(2001) InfectionandActivationof MonocytesbyMarburgand Ebolaviruses. American Societyfor Microbiology:Journalof Virology [Online] 75(22/Nov) p.11025-11033. Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC114683/pdf/jv2201011025.pdf [Accessed10/01/15] WAHL-JENSEN,M, V.etal, (2005) Effectsof EbolaVirusGlycoproteinsonEndothelialCell Activation and BarrierFunction. Journalof Virology. [Online] 79(16) p.10442-10450. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1182673/pdf/2491-04.pdf [Accessed:21/01/15]